光子与质子放化疗对脑组织体积及灌注的影响比较
光子组灰质体积下降2.2%、白质下降1.2%(均P<0.001),质子组无显著变化;灰质体积每增加10 Gy剂量下降0.9%(P<0.001)且两种放疗方式间有差异(P<0.001)。灌注在光子组下降10.1%(P=0.002),质子组下降9.1%但未达统计学显著(P=0.12),且灌注下降与剂量或放疗方式无关。
要点
- 光子放化疗后对侧健康半球灰质体积下降2.2%、白质下降1.2%,质子组无显著变化。
- 灰质体积每增加10 Gy剂量下降0.9%,且光子与质子放疗方式间差异显著。
- 灌注下降在两种放疗方式间程度相当,与剂量及放疗方式均无相关性。
核心结论
- 健康半球组织体积下降取决于所受放疗剂量,且光子与质子放疗方式间存在差异。
- 质子放疗相比光子放疗可能减少脑体积丢失。
- 灌注下降在两种放疗方式间程度相当。
研究设计与样本
- 光子放疗47例,质子放疗19例。
- 放疗前及放疗后3至6个月行T1加权和动脉自旋标记MRI,比较对侧健康半球体积与灌注变化。
主要发现
- 光子组灰质体积下降2.2%(P<0.001)、白质下降1.2%(P<0.001),相比放疗前基线。
- 质子组灰质体积变化0.3%(P=0.64)、白质变化-0.4%(P=0.58),均无显著差异。
- 灰质体积每增加10 Gy剂量下降0.9%(P<0.001),且两种放疗方式间差异显著(P<0.001)。
- 光子组灌注下降10.1%(P=0.002),质子组下降9.1%(P=0.12)。
- 灌注下降与剂量(P=0.64)及放疗方式(P=0.94)均无相关性。
临床怎么用
- 对于胶质母细胞瘤术后放化疗患者,选择质子放疗可能有助于减少对侧健康半球的脑体积丢失。
- 评估脑组织损伤时需考虑健康半球所受放疗剂量,剂量越高灰质体积下降越明显。
局限性
- 质子组样本量(n=19)小于光子组(n=47),组间比较可能受样本量不均衡影响。
- 随访时间仅为放疗后3至6个月,未报告长期变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To compare the structural and hemodynamic changes of healthy brain tissue in the cerebral hemisphere contralateral to the tumor following photon and proton radiochemotherapy. MATERIALS AND METHODS: Sixty-seven patients (54.9 ±14.0 years) diagnosed with glioblastoma undergoing adjuvant photon (n = 47) or proton (n = 19) radiochemotherapy with temozolomide after tumor resection underwent T1-weighted and arterial spin labeling MRI. Changes in volume and perfusion before and 3 to 6 months after were compared between therapies. RESULTS: A decrease in gray matter (GM) (-2.2%, P<0.001) and white matter (WM) (-1.2%, P<0.001) volume was observed in photon-therapy patients compared to the pre-radiotherapy baseline. In contrast, for the proton-therapy group, no significant differences in GM (0.3%, P = 0.64) or WM (-0.4%, P = 0.58) volume were observed. GM volume decreased with 0.9% per 10 Gy dose increase (P<0.001) and differed between the radiation modalities (P<0.001). Perfusion decreased in photon-therapy patients (-10.1%, P = 0.002), whereas the decrease in proton-therapy patients, while comparable in magnitude, did not reach statistical significance (-9.1%, P = 0.12). There was no correlation between perfusion decrease and either dose (P = 0.64) or radiation modality (P = 0.94). CONCLUSIONS: Our results show that the tissue volume decrease depends on radiation dose delivered to the healthy hemisphere and differs between treatment modalities. In contrast, the decrease in perfusion was comparable for both irradiation modalities. We conclude that proton therapy may reduce brain-volume loss when compared to photon therapy.
引用
- Petr J, Platzek I, Hofheinz F, et al. Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion. Radiother Oncol. 2018. PMID: 29370984. doi:10.1016/j.radonc.2017.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。